Cite
APA Citation
Kakizaki, Y., Fujita, T., Takahashi, T., Miwa, T., & Odawara, M. (n.d.). evaluation of the CGMs in type-2 diabetic patients switched from Liraglutide and Insulin Degludec to Liraglutide and Insulin Degludec/Aspart. Diabetes research and clinical practice, 120, S111–. http://access.bl.uk/ark:/81055/vdc_100039989173.0x000055